Abstract
Infectious diseases continue to be of major cause of morbidity and mortality worldwide. It is recognized that therapies that target the immune system have the potential to improve outcome in infectious diseases, but the development of effective immunomodulatory therapies has proven to be quite challenging. One reason underscoring the challenge is that the immune response is a double-edged…